H. Katayama

发表

Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis.

H. Ueoka, T. Miyasho, K. Aoe, 2013, Cytokine.

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma

K. Kiura, M. Tanimoto, S. Umemura, 2012, Cancer science.

Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.

K. Kiura, M. Tanimoto, K. Ohashi, 2009, Lung cancer.

Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2016, Oncology letters.

Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancer.

K. Matsuo, H. Ueoka, K. Tajima, 2007, Asian Pacific journal of cancer prevention : APJCP.

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.

K. Kiura, M. Tabata, H. Ueoka, 2007, Oncology reports.

Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay

S. Toyooka, Masaki Tokumo, K. Kiura, 2006, Clinical Cancer Research.

Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy.

T. Murakami, A. Hiraki, R. Eda, 2005, Anticancer research.

Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers

S. Toyooka, H. Doihara, K. Tomii, 2007, International journal of cancer.

Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

S. Toyooka, K. Matsuo, H. Ueoka, 2007, International journal of cancer.

Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma.

K. Kiura, H. Ueoka, M. Tanimoto, 2002, Anticancer research.

Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.

K. Kiura, M. Tabata, H. Ueoka, 2005, Internal medicine.

Effect of parenteral hydration therapy based on the Japanese national clinical guideline on quality of life, discomfort, and symptom intensity in patients with advanced cancer.

T. Asada, C. Takigawa, T. Morita, 2012, Journal of pain and symptom management.

mediastinal nonseminomatous germ-cell tumor Induction chemotherapy, surgical resection, and high-dose chemotherapy for

K. Kiura, M. Tabata, H. Ueoka, 2013 .

Induction chemotherapy, surgical resection, and high-dose chemotherapy for mediastinal nonseminomatous germ-cell tumor.

M. Tabata, H. Ueoka, M. Tanimoto, 2005, The Journal of thoracic and cardiovascular surgery.

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

J. Soh, S. Toyooka, K. Kiura, 2006, International journal of cancer.

Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.

K. Kiura, M. Tabata, H. Ueoka, 2000, Japanese journal of clinical oncology.

Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer

K. Kiura, M. Aoe, M. Tabata, 2004, British Journal of Cancer.

Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study

Y. Matsuda, S. Iwase, Y. Matsumoto, 2017, Supportive Care in Cancer.

Demand for weekend outpatient chemotherapy among patients with cancer in Japan

K. Kiura, M. Tabata, J. Matsuoka, 2020, Supportive Care in Cancer.

Epstein-Barr Virus Associated Diffuse Large B-Cell Lymphoma Complicated by Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia

T. Yoshino, M. Takeuchi, Kiyoshi Takahashi, 2001, Leukemia & lymphoma.

Advance care planning in metastatic breast cancer.

T. Iwamoto, J. Matsuoka, M. Nishizaki, 2018, Chinese clinical oncology.

How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study

Y. Matsuda, S. Iwase, Y. Matsumoto, 2019, Supportive Care in Cancer.

Relationship between corticosteroid effect on dyspnea, prognosis prediction, and actual survival

K. Kiura, M. Tabata, J. Matsuoka, 2021 .

Advance care planning (ACP)

H. Katayama, 2022, Okayama Igakkai Zasshi (Journal of Okayama Medical Association).

Selective cyclooxygenase-2 inhibitor prevents cisplatin-induced tumorigenesis in A/J mice.

K. Kiura, H. Ueoka, M. Tanimoto, 2012, Acta medica Okayama.

Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study

Y. Matsuda, S. Iwase, Y. Matsumoto, 2016, Supportive Care in Cancer.

Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study.

Y. Matsuda, S. Iwase, Y. Matsumoto, 2016, Journal of pain and symptom management.

Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.

Y. Matsuda, S. Iwase, Y. Matsumoto, 2017, Journal of Palliative Medicine.

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.

K. Kiura, H. Ueoka, M. Tanimoto, 2023, Acta Medica Okayama.

Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)

K. Eguchi, K. Kiura, H. Ueoka, 2000 .

Seismic exploration of Fuji volcano with active sources in 2003

T. Kagiyama, H. Oshima, H. Miyamachi, 2004 .